Maximum residue limit opinions
This page lists the opinions of the Committee for Medicinal Products for Veterinary Use (CVMP) on maximum residue limit (MRL) evaluations.
The MRL is the maximum concentration of residue accepted by the European Union (EU) in a food product obtained from an animal that has received a veterinary medicine. The assessment of the safety of residues is carried out by the CVMP.
Any MRL opinion issued by the CVMP is published in the first instance as a summary of opinion, in line with the Agency's strategy to improve transparency in the regulatory process. The full opinion is published following the publication of the Commission Regulation formally establishing the MRL status and includes the European public MRL assessment report (EPMAR), which provides more detailed information on the scientific evaluation.
CVMP opinions on MRL evaluations are only published for substances evaluated after the entry into force of Regulation (EC) No 470/2009 on 6 July 2009. For all other substances, the EPMARs (formerly called summary reports) are available.
-
List item
Opinion of the CVMP on the establishment of maximum residue limits : Bambermycin (EXTN/0002) (PDF/143.86 KB)
Adopted
First published: 01/07/2022
EMA/CVMP/371780/2021 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Paromomycin (PDF/139.68 KB)
Adopted
First published: 29/07/2021
EMA/CVMP/56181/2018 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Bupivacaine (PDF/107.95 KB)
Adopted
First published: 06/05/2021
EMA/CVMP/70565/2020 -
List item
Opinion of the CVMP on the establishment of maximum residue limits : Imidacloprid (PDF/135.12 KB)
Adopted
First published: 19/04/2021
EMA/CVMP/446874/2020 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Lidocaine (porcine) (PDF/130.37 KB)
Adopted
First published: 25/03/2021
EMA/CVMP/358731/2020 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Bupivacaine (PDF/68.17 KB)
First published: 04/03/2021
EMA/CVMP/278194/2020 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Lidocaine (PDF/54.71 KB)
First published: 04/03/2021
EMA/94693/2021 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Ketoprofen (PDF/139.48 KB)
First published: 06/07/2020
EMA/CVMP/94867/2020 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Ciclesonide (PDF/193.57 KB)
Adopted
First published: 20/05/2020
EMA/CVMP/101968/2019 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Bambermycin (PDF/118.49 KB)
First published: 14/05/2020
EMA/CVMP/202283/2019 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Isoflurane (PDF/63.49 KB)
First published: 17/10/2018
EMA/CVMP/103565/2018 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Eprinomectin (PDF/80.34 KB)
Adopted
First published: 05/09/2018
Last updated: 05/09/2018
EMA/CVMP/698003/2017 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Porcine prolactin (PDF/72.61 KB)
Adopted
First published: 05/09/2018
Last updated: 05/09/2018
EMA/CVMP/698114/2017 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Fluazuron (PDF/76.01 KB)
Adopted
First published: 03/05/2018
Last updated: 03/05/2018
EMA/CVMP/616458/2017 -
List item
Divergent position on a CVMP opinion on the establishment of maximum residue limits: For extension of fluazuron for fin fish (automatic extrapolation to milk) (PDF/24.75 KB)
Adopted
First published: 03/05/2018
Last updated: 03/05/2018 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Solvent naphtha, light aromatic (PDF/77.1 KB)
Adopted
First published: 03/05/2018
Last updated: 03/05/2018
EMA/CVMP/617222/2017 -
List item
Opinion of the Committee for Medicinal Products for Veterinary Use on the establishment of maximum residue limits: Alarelin (PDF/78.2 KB)
Adopted
First published: 02/02/2018
Last updated: 02/02/2018
EMA/CVMP/185578/2017 -
List item
Opinion of the Committee for Medicinal Products for Veterinary Use on the establishment of maximum residue limits: Bromelain (PDF/78.77 KB)
Adopted
First published: 02/02/2018
Last updated: 02/02/2018
EMA/CVMP/255492/2017 -
List item
Opinion of the Committee for Medicinal Products for Veterinary Use on the establishment of maximum residue limits: Fluralaner (PDF/81.06 KB)
Adopted
First published: 17/02/2017
Last updated: 17/02/2017
EMA/CVMP/615777/2016 -
List item
Opinion of the Committee for Medicinal Products for Veterinary Use on the establishment of maximum residue limits: Gamithromycin (PDF/74.12 KB)
Adopted
First published: 12/01/2017
Last updated: 12/01/2017
EMA/CVMP/454065/2016 -
List item
Opinion of the Committee for Medicinal Products for Veterinary Use on the establishment of maximum residue limits: Aluminium salicylate, basic (PDF/76.98 KB)
Adopted
First published: 12/12/2016
Last updated: 12/12/2016
EMA/CVMP/453264/2016 -
List item
Opinion of the Committee for Medicinal Products for Veterinary Use on the establishment of maximum residue limits: Monepantel (PDF/80.38 KB)
Adopted
First published: 16/11/2016
Last updated: 16/11/2016
EMA/CVMP/322539/2016 -
List item
Opinion of the Committee for Medicinal Products for Veterinary Use on the establishment of maximum residue limits: Hydrocortisone aceponate (PDF/74.08 KB)
Adopted
First published: 21/09/2016
Last updated: 21/09/2016 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Eprinomectin (PDF/82.97 KB)
Adopted
First published: 07/07/2016
Last updated: 07/07/2016
EMA/CVMP/779112/2015 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Copper carbonate (PDF/73.09 KB)
Adopted
First published: 27/05/2016
Last updated: 27/05/2016
EMA/CVMP/758984/2015 -
List item
Opinion of the Committee for CVMP on the establishment of maximum residue limits: Rafoxanide (PDF/80.16 KB)
Adopted
First published: 03/05/2016
Last updated: 03/05/2016
EMA/CVMP/705308/2015 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Gentamicin (PDF/80.85 KB)
Adopted
First published: 22/03/2016
Last updated: 22/03/2016
EMA/CVMP/619915/2015 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Purified semi-solid extract from Humulus lupulus L. containing approximately 48% of beta acids (as potassium salts) (PDF/68.39 KB)
Adopted
First published: 17/02/2016
Last updated: 17/02/2016
EMA/CVMP/245930/2015 -
List item
Divergent opinion on maximum residue limits of 'Purified semi-solid extract from Humulus lupulus L. containing approximately 48% of beta acids (as potassium salts)' (PDF/33.51 KB)
First published: 17/02/2016
Last updated: 17/02/2016 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Sisapronil (PDF/74.25 KB)
Adopted
First published: 11/12/2015
Last updated: 11/12/2015
EMA/CVMP/259372/2015 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Diethylene glycol monoethyl ether (PDF/80.46 KB)
Adopted
First published: 20/10/2015
Last updated: 20/10/2015
EMA/CVMP/36684/2015 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Aluminium salicylate, basic (PDF/75.77 KB)
Adopted
First published: 17/09/2015
Last updated: 17/09/2015
EMA/CVMP/587830/2014 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Clodronic acid (PDF/72.79 KB)
Adopted
First published: 09/09/2015
Last updated: 09/09/2015
EMA/CVMP/239251/2014 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Hexaflumuron (PDF/73.25 KB)
Adopted
First published: 09/09/2015
Last updated: 09/09/2015
EMA/CVMP/347690/2014 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Propyl 4-hydroxybenzoate and its sodium salt (PDF/74.89 KB)
Adopted
First published: 09/09/2015
Last updated: 09/09/2015
EMA/CVMP/633015/2014 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Tylvalosin (PDF/81.52 KB)
Adopted
First published: 09/09/2015
Last updated: 09/09/2015
EMA/CVMP/380629/2014 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Virginiamycin (PDF/90.98 KB)
Adopted
First published: 09/09/2015
Last updated: 09/09/2015
EMA/CVMP/643808/2014 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Barium selenate (PDF/79.34 KB)
Adopted
First published: 28/04/2015
Last updated: 28/04/2015
EMA/CVMP/176966/2014 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Potassium selenate, sodium selenate, sodium selenite (PDF/77.99 KB)
Adopted
First published: 28/04/2015
Last updated: 28/04/2015
EMA/CVMP/666932/2014 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Tulathromycin (modification of ADI and MRL) (PDF/88.95 KB)
Adopted
First published: 28/04/2015
Last updated: 28/04/2015
EMA/CVMP/380415/2014 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Doxycycline (PDF/74.93 KB)
Adopted
First published: 10/03/2015
Last updated: 10/03/2015
EMA/CVMP/347869/2014 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Gamithromycin (PDF/67.12 KB)
Adopted
First published: 10/03/2015
Last updated: 10/03/2015
EMA/CVMP/350420/2014 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Methylprednisolone (PDF/66.73 KB)
Adopted
First published: 10/03/2015
Last updated: 10/03/2015
EMA/CVMP/339063/2014 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Tulathromycin (PDF/67.78 KB)
Adopted
First published: 10/03/2015
Last updated: 10/03/2015
EMA/CVMP/303753/2014 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Eprinomectin (PDF/114.38 KB)
Adopted
First published: 17/02/2015
Last updated: 17/02/2015
EMA/CVMP/293995/2014 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Lasalocid (PDF/85.23 KB)
Adopted
First published: 17/02/2015
Last updated: 17/02/2015
EMA/CVMP/154734/2013 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Tulathromycin (PDF/92.67 KB)
Adopted
First published: 17/02/2015
Last updated: 17/02/2015
EMA/CVMP/604655/2013 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Lufenuron (PDF/80.12 KB)
Adopted
First published: 04/02/2015
Last updated: 04/02/2015
EMA/CVMP/651823/2013 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Cabergoline (PDF/87.13 KB)
Adopted
First published: 08/09/2014
Last updated: 08/09/2014
EMA/CVMP/660284/2013 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Clorsulon (PDF/88.19 KB)
Adopted
First published: 08/09/2014
Last updated: 08/09/2014
EMA/CVMP/741367/2013 Rev.1 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Closantel (PDF/89.07 KB)
Adopted
First published: 08/09/2014
Last updated: 08/09/2014
EMA/CVMP/741512/2013 Rev.1 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Rafoxanide (PDF/88.31 KB)
Adopted
First published: 08/09/2014
Last updated: 08/09/2014
EMA/CVMP/672931/2013 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Triclabendazole (PDF/81.5 KB)
Adopted
First published: 08/09/2014
Last updated: 08/09/2014
EMA/CVMP/649894/2013 Rev.1 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Ivermectin (PDF/76.97 KB)
Adopted
First published: 17/06/2014
Last updated: 17/06/2014
EMA/CVMP/497546/2013 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Tildipirosin (PDF/79.75 KB)
Adopted
First published: 14/04/2014
Last updated: 14/04/2014
EMA/CVMP/440151/2013 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Triptorelin acetate (PDF/72.56 KB)
Adopted
First published: 14/04/2014
Last updated: 14/04/2014
EMA/CVMP/383203/2013 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Diclazuril (PDF/81.39 KB)
Adopted
First published: 17/03/2014
Last updated: 17/03/2014
EMA/CVMP/13722/2013 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Butafosfan (PDF/75.54 KB)
Adopted
First published: 17/03/2014
Last updated: 17/03/2014
EMA/CVMP/250946/2013 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Chloroform (PDF/72.09 KB)
Adopted
First published: 17/03/2014
Last updated: 17/03/2014
EMA/CVMP/317099/2013 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Manganese carbonate (PDF/75.47 KB)
Adopted
First published: 27/11/2013
Last updated: 27/11/2013
EMA/CVMP/14468/2013 -
List item
Final opinion of the CVMP on the establishment of maximum residue limits: Neomycin (PDF/76.94 KB)
Adopted
First published: 27/11/2013
Last updated: 27/11/2013
EMA/CVMP/840899/2011 Final, Rev.1 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Monepantel (PDF/76.03 KB)
Adopted
First published: 16/09/2013
Last updated: 16/09/2013
EMA/CVMP/219741/2012 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Prednisolone (PDF/97.08 KB)
Adopted
First published: 30/07/2013
Last updated: 30/07/2013
EMA/CVMP/382060/2012 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Double-stranded ribonucleic acid homologous to viral ribonucleic acid coding for part of the coat protein and part of the intergenic region of the Israe... (PDF/70.3 KB)
Adopted
First published: 30/07/2013
Last updated: 30/07/2013
EMA/CVMP/594122/2012 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Eprinomectin (PDF/88.03 KB)
Adopted
First published: 21/03/2013
Last updated: 21/03/2013
EMA/CVMP/205176/2012 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Diclazuril (PDF/73.52 KB)
Adopted
First published: 14/03/2013
Last updated: 14/03/2013
EMA/CVMP/183880/2012 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Monensin (PDF/69.28 KB)
Adopted
First published: 08/02/2013
Last updated: 08/02/2013
EMA/CVMP/804330/2011- Rev.1 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Fenbendazole (PDF/67.71 KB)
Adopted
First published: 22/01/2013
Last updated: 22/01/2013
EMA/CVMP/845730/2011 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Phoxim (PDF/67.59 KB)
Adopted
First published: 22/01/2013
Last updated: 22/01/2013
EMA/CVMP/78444/2012 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Sodium salicylate (PDF/72.41 KB)
Adopted
First published: 22/01/2013
Last updated: 22/01/2013
EMA/CVMP/63588/2012 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Azamethiphos (PDF/53 KB)
Adopted
First published: 15/06/2012
Last updated: 15/06/2012
EMA/CVMP/149845/2011 – Rev.1 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Clorsulon (PDF/81.4 KB)
Adopted
First published: 15/06/2012
Last updated: 15/06/2012
EMA/CVMP/915840/2011 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Pegylated bovine granulocyte colony stimulating factor (PDF/61.91 KB)
Adopted
First published: 25/05/2012
Last updated: 25/05/2012
EMA/CVMP/293093/2011 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Nitroxinil (PDF/70.96 KB)
Adopted
First published: 23/05/2012
Last updated: 23/05/2012
EMA/CVMP/848524/2011 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Closantel (PDF/79.28 KB)
Adopted
First published: 23/04/2012
Last updated: 23/04/2012
EMA/CVMP/846763/2011 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Triclabendazole (PDF/71.86 KB)
Adopted
First published: 13/04/2012
Last updated: 13/04/2012
EMA/CVMP/848821/2011 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Altrenogest (PDF/72.24 KB)
Adopted
First published: 22/03/2012
Last updated: 22/03/2012
EMA/CVMP/687242/2011 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Octenidine dihydrochloride (PDF/53.29 KB)
Adopted
First published: 22/03/2012
Last updated: 22/03/2012
EMA/CVMP/61867/2011-Rev.1 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Phenoxymethylpenicillin (PDF/71.7 KB)
Adopted
First published: 22/03/2012
Last updated: 22/03/2012
EMA/CVMP/447493/2011 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Monepantel (PDF/54.33 KB)
Adopted
First published: 22/03/2012
Last updated: 22/03/2012
EMA/CVMP/165867/2011-Rev.1 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Lasalocid (PDF/52.36 KB)
Adopted
First published: 22/03/2012
Last updated: 22/03/2012
EMA/CVMP/754527/2010 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Methylprednisolone (PDF/72.08 KB)
Adopted
First published: 22/03/2012
Last updated: 22/03/2012
EMA/CVMP/822069/2010-Rev.1 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Isoeugenol (PDF/61.01 KB)
Adopted
First published: 20/05/2011
Last updated: 20/05/2011
EMA/CVMP/518785/2010 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Monepantel (PDF/58.71 KB)
Adopted
First published: 20/05/2011
Last updated: 20/05/2011
EMA/CVMP/569128/2010 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Sodium Salicylate (PDF/60 KB)
Adopted
First published: 18/11/2010
Last updated: 18/11/2010
EMA/CVMP/13789/2010 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Derquantel (PDF/62.59 KB)
Adopted
First published: 18/11/2010
Last updated: 18/11/2010
EMA/CVMP/261782/2010 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Tildipirosin (PDF/80.17 KB)
Adopted
First published: 26/10/2010
Last updated: 26/10/2010 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Methylprednisolone (PDF/36.4 KB)
Adopted
First published: 26/10/2010
Last updated: 26/10/2010 -
List item
Opinion of the CVMP on the establishment of maximum residue limits: Valnemulin (PDF/28.58 KB)
Adopted
First published: 26/10/2010
Last updated: 26/10/2010